Avalyn Pharma Inc. Files Initial Ownership Statement
Ticker: AVLN · Form: 3 · Filed: Apr 30, 2026 · CIK: 0001540171
| Field | Detail |
|---|---|
| Company | Avalyn Pharma Inc. (AVLN) |
| Form Type | 3 |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, ownership, sec-form-3
TL;DR
Avalyn Pharma Inc. just filed its initial ownership docs (Form 3) on 4/29/26. Transparency incoming!
AI Summary
On April 29, 2026, Avalyn Pharma Inc. filed a Form 3, an initial statement of beneficial ownership of securities. The filing was made by FMR LLC, which is listed as the reporting entity. The document details the initial ownership of securities by an insider or a new issuer.
Why It Matters
This filing marks the initial disclosure of beneficial ownership for Avalyn Pharma Inc., providing transparency on who holds significant stakes in the company from the outset.
Risk Assessment
Risk Level: low — A Form 3 filing is a standard procedural document for initial ownership disclosure and does not inherently indicate financial risk.
Key Players & Entities
- Avalyn Pharma Inc. (company) — Issuer
- FMR LLC (company) — Reporting Entity
- 0001540171 (company) — Avalyn Pharma Inc. CIK
- 0000315066 (company) — FMR LLC CIK
- 2026-04-29 (date) — Filing Date and Period of Report
FAQ
What type of SEC filing is this?
This is a Form 3, an Initial Statement of Beneficial Ownership of Securities.
Who is the issuer in this filing?
The issuer is Avalyn Pharma Inc. (CIK: 0001540171).
Who is the reporting entity for this filing?
The reporting entity is FMR LLC (CIK: 0000315066).
When was this filing made?
The filing date was April 29, 2026.
What is the purpose of a Form 3 filing?
A Form 3 is used to report the initial beneficial ownership of securities by an insider or a new issuer.
Filing Details
This Initial Statement of Beneficial Ownership (Form 3) was filed with the SEC on April 30, 2026 regarding Avalyn Pharma Inc. (AVLN). Form 3 filings establish the initial ownership position of company insiders when they first assume their role.